Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q2 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
Q4 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
Q1 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q2 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q4 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q1 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
Q2 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q3 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q4 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q1 2028 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q2 2028 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q3 2028 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q4 2028 | 1 | -$0.07 | -$0.07 | -$0.07 |
Anixa Biosciences, Inc. last posted its earnings results on Friday, September 6th, 2024. The company reported $-0.1 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.01. The company had revenue of 0 for the quarter and had revenue of 210,000 for the year. Anixa Biosciences, Inc. has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -6.66. Anixa Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 1st, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
09/06/2024 | Q3 2024 | -$0.11 | -$0.10 | 0.01 | $0 | $0 |
06/04/2024 | Q2 2024 | -$0.11 | -$0.10 | 0.01 | $0 | |
03/12/2024 | Q1 2024 | -$0.09 | -$0.10 | -0.01 | $0 | |
01/16/2024 | Q4 2023 | -$0.09 | -$0.09 | 0 | $156,000 | |
09/06/2023 | Q3 2023 | -$0.09 | -$0.08 | 0.01 | $0 | |
06/14/2023 | Q2 2023 | -$0.11 | -$0.07 | 0.04 | $210,000 | |
03/16/2023 | Q1 2023 | -$0.07 | $0 | |||
01/04/2023 | Q4 2022 | -$0.13 | -$0.11 | 0.02 | $2.47 B | |
07/31/2022 | Q3 2022 | -$0.09 | $0 | |||
06/10/2022 | Q2 2022 | -$0.13 | -$0.12 | 0.01 | $0 | |
03/11/2022 | Q1 2022 | -$0.13 | -$0.13 | 0 | $0 | |
01/04/2022 | Q4 2021 | -$0.13 | $3.61 M | |||
09/01/2021 | Q3 2021 | -$0.08 | -$0.14 | -0.06 | $0 | |
06/10/2021 | Q2 2021 | -$0.10 | -$0.08 | 0.02 | $0 | |
03/11/2021 | Q1 2021 | -$0.11 | -$0.09 | 0.02 | $512,500 | |
01/07/2021 | Q4 2020 | -$0.09 | $-124,360 | |||
09/08/2020 | Q3 2020 | -$0.12 | -$0.11 | 0.01 | $0 | |
06/09/2020 | Q2 2020 | -$0.12 | -$0.12 | 0 | $0 | |
03/09/2020 | Q1 2020 | -$0.13 | -$0.13 | 0 | $0 | |
01/09/2020 | Q4 2019 | -$0.24 | -$0.10 | 0.14 | $-259,481 |
Anixa Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 1st, 2025 based off last year's report dates.
In the previous quarter, Anixa Biosciences, Inc. (:ANIX) reported $-0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.01.
The conference call for Anixa Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Anixa Biosciences, Inc.'s latest earnings report can be read online.
Anixa Biosciences, Inc. (:ANIX) has a recorded annual revenue of $210,000.
Anixa Biosciences, Inc. (:ANIX) has a recorded net income of $210,000. Anixa Biosciences, Inc. has generated $-0.32 earnings per share over the last four quarters.
Anixa Biosciences, Inc. (:ANIX) has a price-to-earnings ratio of -6.66 and price/earnings-to-growth ratio is 2.47.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED